Understanding Pfizer’s RSV vaccine risks and benefits

Understanding Pfizer’s RSV vaccine risks and benefits

June 15, 2026 · 57 min

About this episode

The episode discusses the risks and benefits of Pfizer’s RSV vaccine for pregnant women, highlighting concerns about preterm birth and neurologic events.

Informed Dissent with Dr. Jeff Barke – Take the recent respiratory syncytial virus vaccine for pregnant women. The manufacturer’s label notes postmarketing reports of increased preterm birth and of neurologic events such as Guillain-Barré syndrome. The label lists residual host cell proteins from Chinese hamster ovary cells and polysorbate 80 among components...

People in this episode

Host: Dr. Jeff Barke

Topics covered

Keywords

Mentioned in this episode

Organizations: Chinese hamster ovary cells

Products: Pfizer’s RSV vaccine

More episodes of Informed Dissent

Explore listener stats, chart rankings, contacts and more on the Informed Dissent podcast page.